CRC (Colorectal Cancer)

Oncology
1
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

TG Therapeutics
TG TherapeuticsNEW YORK, NY
1 program
1
TGI-5Phase 11 trial
Active Trials
NCT07376707RecruitingEst. Dec 2027
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
cfDNA 5mC/5hmC SequencingN/A1 trial
Active Trials
NCT07224841RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
TG TherapeuticsTGI-5
City TherapeuticscfDNA 5mC/5hmC Sequencing

Clinical Trials (2)

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Start: Jun 2025Est. completion: Dec 2027
Phase 1Recruiting
NCT07224841City TherapeuticscfDNA 5mC/5hmC Sequencing

Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC

Start: Jun 2024Est. completion: Jun 2026
N/ARecruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials
2 companies competing in this space